Is there a place for cardiovascular magnetic resonance conditional devices in systemic inflammatory diseases?

References

• Seferović PM, Ristić AD, Maksimović R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006;45(Suppl 4):iv39–42. doi:10.1093/rheumatology/kel315.
   PubMed Web of Science ®Google Scholar
• Kumar S, Barbhaiya C, Nagashima K, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8(1):87–93. doi:10.1161/CIRCEP.114.002145.
   PubMed Web of Science ®Google Scholar
• Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16(2):140–147. doi:10.1111/j.1542-474X.2011.00418.x.
   PubMed Web of Science ®Google Scholar
• Kron J, Sauer W, Mueller G, et al. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator. J Interv Card Electrophysiol. 2015;43(1):55–64. doi:10.1007/s10840-015-9978-3.
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Capecchi PL, Acampa M, et al. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev. 2014;13(9):936–944. doi:10.1016/j.autrev.2014.05.007.
   PubMed Web of Science ®Google Scholar
• Crowson CS, Liao KP, Davis JM 3rd, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166(4):622–628.e1. doi:10.1016/j.ahj.2013.07.010.
   PubMed Web of Science ®Google Scholar
• Teixeira RA, Borba EF, Bonfá E, et al. Arrhythmias in systemic lupus erythematosus. Rev Bras Reumatol. 2010;50(1):81–89.
   PubMedGoogle Scholar
• Huang C-N, Yu H-H, Chiu S-N, et al. Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus. Rheumatol Int. 2013;33(4):1093–1096. doi:10.1007/s00296-011-2240-0.
   PubMed Web of Science ®Google Scholar
• Jindal G, Singh S, Suri D, et al. Recurrent ventricular tachycardia in a child with juvenile dermatomyositis: an unusual association. Int J Rheum Dis. 2012;15(2):e26–7. doi:10.1111/j.1756-185X.2012.01701.x.
   Google Scholar
• Dilaveris P, Pietri P, Tsiachris D, et al. Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy. Circulation. 2012;125(7):967–969. doi:10.1161/CIRCULATIONAHA.111.049882.
   PubMed Web of Science ®Google Scholar
• Adler M, Banerjeee S, Stratton R. Ventricular tachycardia as a presenting feature of dermatomyositis. Heart. 2002;88(5):443. doi:10.1136/heart.88.5.443.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Douskou M, Manoussakis MN. Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations. JACC Cardiovasc Imaging. 2011;4(12):1324–1325. doi:10.1016/j.jcmg.2011.05.009.
   PubMed Web of Science ®Google Scholar
• Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–881. doi:10.1111/jce.12401.
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Tsuno H, Kaneko S, et al. Complete atrioventricular block and aseptic meningitis in a patient with adult-onset Still’s disease and concurrent hemophagocytic syndrome. Mod Rheumatol. 2015;25(2):332–333. doi:10.3109/14397595.2014.882220.
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301–312. doi:10.1038/nrrheum.2015.29.
   PubMed Web of Science ®Google Scholar
• Bergfeldt L, Edhag O, Vedin L, et al. Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men. Am J Med. 1982;73(2):187–191.
   PubMed Web of Science ®Google Scholar
• Alyan O, Ozdemir O, Geyik B, et al. Polymyositis complicated with complete atrioventricular block: a case report and review of the literature. Angiology. 2003;54(6):729–731.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Petrou E, Kolovou G, et al. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2013;14(6):518–525. doi:10.1093/ehjci/jes302.
   PubMed Web of Science ®Google Scholar
• Neilan TG, Farhad H, Mayrhofer T, et al. Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging. 2015;8(4):414–423. doi:10.1016/j.jcmg.2014.11.017.
   PubMed Web of Science ®Google Scholar
• Chimura M, Kiuchi K, Okajima K, et al. Distribution of ventricular fibrosis associated with life threatening ventricular tachyarrhythmias in patients with nonischemic dilated cardiomyopathy. J Cardiovasc Electrophysiol. 2015 Jul 29. doi:10.1111/jce.12767.
   PubMed Web of Science ®Google Scholar
• Chen Z, Sohal M, Voigt T, et al. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. Heart Rhythm. 2015;12(4):792–801. doi:10.1016/j.hrthm.2014.12.020.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Sfikakis PP, Karabela G, et al. “All roads lead to Rome” ventricular tachycardia due to right ventricle involvement in autoimmune and non-autoimmune disease. Int J Cardiol. 2014;173(1):126–127. doi:10.1016/j.ijcard.2014.02.019.
   PubMed Web of Science ®Google Scholar
• Molaee P, Teo KS, Wong DT, et al. Cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis: presenting as ventricular tachycardia. Tex Heart Inst J. 2011;38(5):602–603.
   PubMed Web of Science ®Google Scholar
• Crawford T, Mueller G, Sarsam S, et al. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7(6):1109–1115. doi:10.1161/CIRCEP.113.000156.
   PubMed Web of Science ®Google Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–511. doi:10.1016/j.jcmg.2012.10.021.
   PubMed Web of Science ®Google Scholar
• Nadel J, Lancefield T, Voskoboinik A, et al. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart J Cardiovasc Imaging. 2015;16(6):634–641. doi:10.1093/ehjci/jeu294.
   PubMed Web of Science ®Google Scholar
• Dohi K, Nakamori S, Kurita T, et al. Arrhythmogenic right ventricular cardiomyopathy in a 20-year-old woman with systemic sclerosis. Intern Med. 2014;53(9):973–977.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Sfikakis PP, Gialafos E, et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken). 2014;66(1):104–112. doi:10.1002/acr.22181.
   PubMed Web of Science ®Google Scholar
• Varma N, Hinojar R, D’Cruz D, et al. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients. JACC Cardiovasc Imaging. 2014 Aug;7(8):762–770. doi:10.1016/j.jcmg.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kobayashi H, Giles JT, et al. Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis. 2015 Oct 20. doi:10.1111/1756-185X.12632.
   Google Scholar
• Kobayashi Y, Giles JT, Hirano M, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010;12(5):R171. doi:10.1186/ar3131.
   Google Scholar
• Mavrogeni S, Dimitroulas T, Gabriel S, et al. Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging. Rev Cardiovasc Med. 2014;15(4):320–331.
   PubMed Web of Science ®Google Scholar
• Miszalski-Jamka T, Szczeklik W, Sokołowska B, et al. Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Am Coll Cardiol. 2015;65(1):103–105. doi:10.1016/j.jacc.2014.08.055.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Karabela G, Stavropoulos E, et al. Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance. Int J Cardiol. 2014;176(2):559–561. doi:10.1016/j.ijcard.2014.07.016.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Sfikakis PP, Karabela G, et al. Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol. 2014;171(1):82–87. doi:10.1016/j.ijcard.2013.11.059.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Karabela G, Stavropoulos E, et al. Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. Int J Cardiol. 2013;168(4):4333–4335. doi:10.1016/j.ijcard.2013.05.085.
   PubMed Web of Science ®Google Scholar
• Barraclough M, Elliott R, McKie S, et al. Cognitive dysfunction and functional magnetic resonance imaging in systemic lupus erythematosus. Lupus. 2015;24(12):1239–1247. doi:10.1177/0961203315593819.
   PubMed Web of Science ®Google Scholar
• Ercan E, Ingo C, Tritanon O, et al. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus. Neuroimage Clin. 2015;8:337–344. doi:10.1016/j.nicl.2015.05.002.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis WP, Van Steenbergen HW, Stomp W, et al. The course of bone marrow edema in early undifferentiated and rheumatoid arthritis: a longitudinal MRI study on bone level. Arthritis Rheumatol. 2015 Dec 17. doi:10.1002/art.39550.
   PubMedGoogle Scholar
• Berzigotti A, Frigato M, Manfredini E, et al. Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. World J Gastroenterol. 2011;17(40):4503–4508. doi:10.3748/wjg.v17.i40.4503.
   PubMed Web of Science ®Google Scholar
• Lecouvet FE, Michoux N, Nzeusseu Toukap A, et al. The increasing spectrum of indications of whole-body MRI beyond oncology: imaging answers to clinical needs. Semin Musculoskelet Radiol. 2015 Sep;19(4):348–362. doi:10.1055/s-0035-1564695.
   PubMed Web of Science ®Google Scholar
• Zhou AY, Muir L, Harris J, et al. The impact of magnetic resonance imaging in early diagnosis of hand osteomyelitis in patients with systemic sclerosis. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S–232.
   Google Scholar
• Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pace. 2005;28:326–328. doi:10.1111/j.1540-8159.2005.50024.x.
   Google Scholar
• Lowe MD, Plummer CJ, Manisty CH, et al. Safe use of MRI in people with cardiac implantable electronic devices. Heart. 2015;101(24):1950–1953. doi:10.1136/heartjnl-2015-308495.
   PubMed Web of Science ®Google Scholar
• Femenía F, Arce M, Arrieta M. Systemic sclerosis complicated with syncope and complete AV block. Medicina (B Aires). 2010;70(5):442–444.
   PubMed Web of Science ®Google Scholar
• Oe K, Mori K, Gommori S, et al. Syncope due to paroxysmal atrioventricular block in a patient with systemic sclerosis: a case report. Angiology. 2008;59(6):769–771. doi:10.1177/0003319707307216.
   PubMed Web of Science ®Google Scholar
• Moyssakis I, Papadopoulos DP, Tzioufas AG, et al. Complete heart block in a patient with systemic sclerosis. Clin Rheumatol. 2006;25(4):551–552. doi:10.1007/s10067-005-0068-2.
   PubMed Web of Science ®Google Scholar
• Levesque K, Morel N, Maltret A, et al., “Lupus néonatal” group; Group of collaborators. Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome. Autoimmun Rev. 2015;14(12):1154–1160. doi:10.1016/j.autrev.2015.08.005.
   PubMed Web of Science ®Google Scholar
• Haydin S, Ozturk E, Ergul Y, et al. Intrathoracic implantation of a dual-chamber pacemaker in a preterm infant with congenital AV block. J Card Surg. 2013;28(2):196–198. doi:10.1111/jocs.12068.
   PubMed Web of Science ®Google Scholar
• Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-tesla. J Am Coll Cardiol. 2004;43:1315–1324. doi:10.1016/j.jacc.2003.12.016.
   PubMed Web of Science ®Google Scholar
• Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285–1292. doi:10.1161/CIRCULATIONAHA.105.597013.
   PubMed Web of Science ®Google Scholar
• Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. An Int Med. 2011;155:415–424. doi:10.7326/0003-4819-155-7-201110040-00004.
   PubMed Web of Science ®Google Scholar
• Cohen JD, Costa HS, Russo RJ. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol. 2012;110:1631–1636. doi:10.1016/j.amjcard.2012.07.033.
   PubMed Web of Science ®Google Scholar
• Del Ojo JL, Moya F, Villalba J, et al. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pace. 2005;28:274–278. doi:10.1111/j.1540-8159.2005.50033.x.
   Google Scholar
• Naehle CP, Meyer C, Thomas D, et al. Safety of brain 3-t MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology. 2008;249:991–1001. doi:10.1148/radiol.2493072195.
   PubMed Web of Science ®Google Scholar
• Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pace. 2008;31:795–801. doi:10.1111/j.1540-8159.2008.01117.x.
   Google Scholar
• Coman JA, Sandler DA, Thomas JR. Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 tesla. Am Heart Assoc. 2004;43:138A.
   Google Scholar
• Naehle CP, Strach K, Thomas D, et al. Magnetic resonance imaging at 1.5-t in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 2009;54:549–555. doi:10.1016/j.jacc.2009.04.050.
   PubMed Web of Science ®Google Scholar
• Pulver AF, Puchalski MD, Bradley DJ, et al. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pace. 2009;32:450–456. doi:10.1111/j.1540-8159.2009.02304.x.
   Google Scholar
• Gimbel JR, Kanal E, Schwartz KM, et al. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pace. 2005;28:270–273. doi:10.1111/j.1540-8159.2005.09520.x.
   Google Scholar
• Naehle CP, Kreuz J, Strach K, et al. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 t. Am Heart J. 2011;161:1096–1105. doi:10.1016/j.ahj.2011.03.007.
   PubMed Web of Science ®Google Scholar
• Mesubi O, Ahmad G, Jeudy J, et al. Impact of ICD artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation. Pace. 2014;37:1274–1283. doi:10.1111/pace.12405.
   Google Scholar
• Nordbeck P, Ertl G, Ritter O. Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? Eur Heart J. 2015;36:1505–1511. doi:10.1093/eurheartj/ehv086.
   PubMed Web of Science ®Google Scholar